stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / IART / Gross Profit

Integra LifeSciences Holdings Corporation Gross Profit 2008–2025

Integra LifeSciences Holdings Corporation (IART) annual gross profit by fiscal year, computed from SEC filings.

Fiscal yearGross ProfitGross marginChange (YoY)
FY 2025$831.62M50.9%-5.7%
FY 2024$882.06M54.8%-0.3%
FY 2023$884.74M57.4%-8.8%
FY 2022$970.31M62.3%+2.7%
FY 2021$944.64M61.2%+11.0%
FY 2020$851.03M62.0%-10.7%
FY 2019$952.88M62.8%+5.8%
FY 2018$900.95M61.2%+19.7%
FY 2017$752.73M63.3%+17.1%
FY 2016$642.99M64.8%+15.6%
FY 2015$556.19M+12.6%
FY 2014$493.77M+276.6%
FY 2013$-279.55M+11.1%
FY 2012$-314.43M-5.1%
FY 2011$-299.15M-11.5%
FY 2010$-268.19M-9.5%
FY 2009$-244.92M+3.1%
FY 2008$-252.83M

Source: Integra LifeSciences Holdings Corporation SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for Integra LifeSciences Holdings Corporation

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Integra LifeSciences Holdings Corporation — frequently asked questions

What is Integra LifeSciences Holdings Corporation's gross profit?

Integra LifeSciences Holdings Corporation (IART) reported gross profit of $831.62M for fiscal year 2025, per its SEC filings.

Where does this data come from?

Figures are computed from Integra LifeSciences Holdings Corporation's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More IART financial history

Full IART fundamentals page → · All 1,500+ companies →